down arrow

Surgical Science Sweden AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0014428512
SEK
34.74
1.64 (4.95%)

Dec 04

OME

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Getinge AB
BONESUPPORT HOLDING AB
CellaVision AB
Surgical Science Sweden AB
Vitrolife AB
Biotage AB
MedCap AB
Elekta AB
Genovis AB
Bactiguard Holding AB
Xvivo Perfusion AB
Why is Surgical Science Sweden AB ?
1
Negative results in Mar 25
  • OPERATING CASH FLOW(Y) Lowest at SEK 103.78 MM
  • NET PROFIT(HY) At SEK 88.56 MM has Grown at -27.26%
  • ROCE(HY) Lowest at 3.11%
2
Below par performance in long term as well as near term
  • Along with generating -76.30% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Surgical Science Sweden AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Surgical Science Sweden AB
-76.3%
-0.94
79.61%
OMX Stockholm 30
8.01%
0.44
18.11%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
53.19%
EBIT Growth (5y)
45.86%
EBIT to Interest (avg)
47.45
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
0.20
Tax Ratio
20.05%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.57%
ROE (avg)
4.01%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
39
Industry P/E
Price to Book Value
1.02
EV to EBIT
25.80
EV to EBITDA
17.42
EV to Capital Employed
1.02
EV to Sales
3.99
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.95%
ROE (Latest)
2.59%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -6.5% (YoY

CASH AND EQV(HY)

Highest at SEK 1,581.05 MM

OPERATING PROFIT(Q)

Highest at SEK 65.83 MM

PRE-TAX PROFIT(Q)

Highest at SEK 72.71 MM

NET PROFIT(Q)

Highest at SEK 52.3 MM

-9What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at SEK 103.78 MM

NET PROFIT(HY)

At SEK 88.56 MM has Grown at -27.26%

ROCE(HY)

Lowest at 3.11%

Here's what is working for Surgical Science Sweden AB
Pre-Tax Profit
At SEK 72.71 MM has Grown at 83.97%
over average net sales of the previous four periods of SEK 39.52 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (SEK MM)

Operating Profit
Highest at SEK 65.83 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Pre-Tax Profit
Highest at SEK 72.71 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Net Profit
Highest at SEK 52.3 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (SEK MM)

Net Profit
At SEK 52.3 MM has Grown at 58.9%
over average net sales of the previous four periods of SEK 32.91 MM
MOJO Watch
Near term Net Profit trend is positive

Net Profit (SEK MM)

Cash and Eqv
Highest at SEK 1,581.05 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by -6.5% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at SEK 18.81 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (SEK MM)

Here's what is not working for Surgical Science Sweden AB
Operating Cash Flow
Lowest at SEK 103.78 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (SEK MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."